Search results
Results from the WOW.Com Content Network
Buick "New Century" (China) The Buick Century was produced in China as the New Century from 1998 to 2000. The engine was the 3.0 liter LW9 V6 engine which was also used in the first-generation Buick GL8. A four-cylinder model was also available paired with a 5-speed manual gearbox. The Century was replaced by the Buick Regal due to poor sales. [31]
The Buick Special was an automobile produced by Buick. It was usually Buick's lowest-priced model, starting out as a full-size car in 1936 and returning in 1961 (after a two-year hiatus) as a mid-size. The Special was built for several decades and was offered as a coupe, sedan and later as a station wagon.
The 322 Fireball V8 in a 1956 Buick Century. Buick's first generation V8 was offered from 1953 through 1956; it replaced the Buick straight-eight.While officially called the "Fireball V8" [1] by Buick, it became known by enthusiasts as the "Nailhead" for the unusual vertical alignment of its small-sized valves (Originally it was known to hot-rodders as the "nail valve", because the engine's ...
From the early twentieth century, a Latin letter-based naming scheme was used to designate platforms, [1] which were aimed at vehicles under different brands that served similar niches of the market. For example, the B platform was the base for fullsize , rear-wheel drive (RWD) sedans and wagons from 1926 to 1996.
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.
An Indiana school bus driver was busted for allegedly driving under the influence — with some of the 32 kids on her bus calling in to report her driving them erratically, authorities said.
On Thursday night, the Arkansas State Red Wolves defeated the Bowling Green Falcons in the 68 Ventures Bowl 38 to 31.
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently approved medicine, Zepbound, but didn’t cleanly surpass it in late ...